Goldman Has 'Serious Trust Issue': Yale's Sonnenfeld

The reaction to a departing Goldman Sachs official's scathing column in the New York Times Wednesday shows the bank has "a serious trust issue here and they have to acknowledge that," Jeffrey Sonnenfeld told CNBC Thursday.

The Goldman Sachs booth on the floor of the New York Stock Exchange
Getty Images
The Goldman Sachs booth on the floor of the New York Stock Exchange

"We’re on thin ice here," said Sonnenfeld, a senior associate dean at Yale's School of Management. He referenced King Henry VIII's adviser Sir Thomas More in stressing the "importance of institutional trust. It's as fragile as the liquid cup in your hand. Once you separate the fingers, it's forever gone."

Goldman's board of directors "has to pay attention," he said, adding, "They can’t say losing almost $2.25 billion [in stock value] on one article written by a disgruntled employee is something to ignore."

The op-ed piece by Greg Smith, an executive director who resigned from Goldman, detailed his concerns the bank puts its profits ahead of client needs.

"The firm changed the way it thought about leadership," Smith wrote. "Leadership used to be about ideas, setting an example and doing the right thing. Today, if you make enough money for the firm (and are not currently an ax murderer) you will be promoted into a position of influence."

That's the very thing Sonnenfeld said Goldman needs to do: Live up to its reputation.

"They have to live the brand. If they can’t be the boy scouts, don’t act that way," he said. "Goldman shouldn’t advertise that this is who they are if they can’t live by it. If they are no better than the competition, don’t say you are."

Goldman said in its official response Wednesday it disagreed with Smith's views, "which we don't think reflect the way we run our business."



  • The Marriner S. Eccles Federal Reserve building in Washington.

    CNBC's Fed Survey shows market pros aren't very confident the Fed can end its easy money polices without a market crash, a recession or bad inflation.

  • Merck employees walk past a Merck sign in front of the company's building in Summit, New Jersey.

    Merck reported better-than-expected results, with sales of newer drugs offsetting declining sales of drugs facing generic competition.

  • Pfizer reported higher-than-expected second-quarter earnings, helped by growing sales of its cancer medicines.

  • An attendee is silhouetted against a Microsoft poster at the Microsoft Developers Build Conference in San Francisco, April 2, 2014.

    An agency that enforces antimonopoly laws visited company offices in four cities, as the country more closely scrutinizes multinational companies.

Contact U.S. News


    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video